These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 18544603)

  • 1. Does pre-exposure of Aspergillus fumigatus to voriconazole or posaconazole in vitro affect its virulence and the in vivo activity of subsequent posaconazole or voriconazole, respectively? A study in a fly model of aspergillosis.
    Lamaris GA; Ben-Ami R; Lewis RE; Kontoyiannis DP
    J Antimicrob Chemother; 2008 Sep; 62(3):539-42. PubMed ID: 18544603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased virulence of Zygomycetes organisms following exposure to voriconazole: a study involving fly and murine models of zygomycosis.
    Lamaris GA; Ben-Ami R; Lewis RE; Chamilos G; Samonis G; Kontoyiannis DP
    J Infect Dis; 2009 May; 199(9):1399-406. PubMed ID: 19358672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interstrain variability in the virulence of Aspergillus fumigatus and Aspergillus terreus in a Toll-deficient Drosophila fly model of invasive aspergillosis.
    Ben-Ami R; Lamaris GA; Lewis RE; Kontoyiannis DP
    Med Mycol; 2010 Mar; 48(2):310-7. PubMed ID: 19642052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparative study of fungicidal activities of voriconazole and amphotericin B against hyphae of Aspergillus fumigatus.
    Krishnan S; Manavathu EK; Chandrasekar PH
    J Antimicrob Chemother; 2005 Jun; 55(6):914-20. PubMed ID: 15824093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toll-deficient Drosophila flies as a fast, high-throughput model for the study of antifungal drug efficacy against invasive aspergillosis and Aspergillus virulence.
    Lionakis MS; Lewis RE; May GS; Wiederhold NP; Albert ND; Halder G; Kontoyiannis DP
    J Infect Dis; 2005 Apr; 191(7):1188-95. PubMed ID: 15747256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Voriconazole pre-exposure selects for breakthrough mucormycosis in a mixed model of Aspergillus fumigatus-Rhizopus oryzae pulmonary infection.
    Lewis RE; Liao G; Wang W; Prince RA; Kontoyiannis DP
    Virulence; 2011; 2(4):348-55. PubMed ID: 21788730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Posaconazole after previous antifungal therapy with voriconazole for therapy of invasive aspergillus disease, a retrospective analysis.
    Heinz WJ; Egerer G; Lellek H; Boehme A; Greiner J
    Mycoses; 2013 May; 56(3):304-10. PubMed ID: 23170837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful treatment with voriconazole of Aspergillus brain abscess in a boy with medulloblastoma.
    Stiefel M; Reiss T; Staege MS; Rengelshausen J; Burhenne J; Wawer A; Foell JL
    Pediatr Blood Cancer; 2007 Aug; 49(2):203-7. PubMed ID: 16333861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of voriconazole in Japanese quail (Coturnix japonica) experimentally infected with Aspergillus fumigatus.
    Tell LA; Clemons KV; Kline Y; Woods L; Kass PH; Martinez M; Stevens DA
    Med Mycol; 2010 Mar; 48(2):234-44. PubMed ID: 19548171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and pharmacodynamics of voriconazole combined with anidulafungin in azole-resistant invasive aspergillosis.
    Seyedmousavi S; Brüggemann RJ; Melchers WJ; Rijs AJ; Verweij PE; Mouton JW
    J Antimicrob Chemother; 2013 Feb; 68(2):385-93. PubMed ID: 23129729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo efficacy of voriconazole and posaconazole therapy in a novel invertebrate model of Aspergillus fumigatus infection.
    Forastiero A; Bernal-Martínez L; Mellado E; Cendejas E; Gomez-Lopez A
    Int J Antimicrob Agents; 2015 Nov; 46(5):511-7. PubMed ID: 26358971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Post-antifungal effect of amphotericin B and voriconazole against germinated Aspergillus fumigatus conidia.
    Chryssanthou E; Loebig A; Sjölin J
    J Antimicrob Chemother; 2008 Jun; 61(6):1309-11. PubMed ID: 18367461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolation of multiple-triazole-resistant Aspergillus fumigatus strains carrying the TR/L98H mutations in the cyp51A gene in India.
    Chowdhary A; Kathuria S; Randhawa HS; Gaur SN; Klaassen CH; Meis JF
    J Antimicrob Chemother; 2012 Feb; 67(2):362-6. PubMed ID: 22028200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Virulence studies of Scedosporium and Fusarium species in Drosophila melanogaster.
    Lamaris GA; Chamilos G; Lewis RE; Kontoyiannis DP
    J Infect Dis; 2007 Dec; 196(12):1860-4. PubMed ID: 18190268
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Kimura G; Nakaoki T; Colley T; Rapeport G; Strong P; Ito K; Kizawa Y
    Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28630185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of oleylphosphocholine (OlPC) in vitro and in a mouse model of invasive aspergillosis.
    Paulussen C; Boulet G; Bosschaerts T; Cos P; Fortin A; Maes L
    Mycoses; 2015 Mar; 58(3):127-32. PubMed ID: 25590577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antifungal synergy of a topical triazole, PC945, with a systemic triazole against respiratory Aspergillus fumigatus infection.
    Colley T; Sehra G; Daly L; Kimura G; Nakaoki T; Nishimoto Y; Kizawa Y; Strong P; Rapeport G; Ito K
    Sci Rep; 2019 Jul; 9(1):9482. PubMed ID: 31263150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of cyp51A mutations on the pharmacokinetic and pharmacodynamic properties of voriconazole in a murine model of disseminated aspergillosis.
    Mavridou E; Bruggemann RJ; Melchers WJ; Verweij PE; Mouton JW
    Antimicrob Agents Chemother; 2010 Nov; 54(11):4758-64. PubMed ID: 20733046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased frequency of non-fumigatus Aspergillus species in amphotericin B- or triazole-pre-exposed cancer patients with positive cultures for aspergilli.
    Lionakis MS; Lewis RE; Torres HA; Albert ND; Raad II; Kontoyiannis DP
    Diagn Microbiol Infect Dis; 2005 May; 52(1):15-20. PubMed ID: 15878437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Attenuation of itraconazole fungicidal activity following preexposure of Aspergillus fumigatus to fluconazole.
    Liu W; Lionakis MS; Lewis RE; Wiederhold N; May GS; Kontoyiannis DP
    Antimicrob Agents Chemother; 2003 Nov; 47(11):3592-7. PubMed ID: 14576123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.